• IgG Subclasses
  • MSK-IMPACT™, Solid Organ Gene Cancer Panel
  • Complement Component C3, Nephritic Factor
  • Gamma-hydroxybutyric Acid (GHB), Urine
  • Tissue Transglutaminase (tTG) Antibody, IgA
  • D-Dimer
  • The Oncotype DX Colon Cancer, Recurrence Score®
  • Biopsy, Bone Marrow
  • Hepatitis C Virus (HCV) NS3/4A Protease Inhibitor Resistance, GenoSure
  • Neisseria gonorrhoeae Nucleic Acid, Liquid Cytology
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Myosin regulatory light chain 2 (MYL2) Gene Mutation Analysis
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Myosin regulatory light chain 2 (MYL2) Gene Mutation Analysis
Medical Test

Diseases (1)
Access to Myosin regulatory light chain 2 (MYL2) Gene Mutation Analysis is restricted.